A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas.
about
Targeted immunotherapy for pediatric solid tumorsImmunotherapy of Childhood SarcomasUnderstanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionAdoptive cell therapy for sarcomaCellular immunotherapy for pediatric solid tumorsCurrent Immunotherapies for Sarcoma: Clinical Trials and RationaleImmunotherapy for Bone and Soft Tissue SarcomasImmune-based therapeutics for pediatric cancer.Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.T-cell-based therapies for malignancy and infection in childhood.Immunotherapy of childhood cancer: from biologic understanding to clinical application.New strategies in ewing sarcoma: lost in translation?Immunotherapeutic Intervention against Sarcomas.Targeted Therapy of Ewing's Sarcoma.The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research.Common Ewing sarcoma-associated antigens fail to induce natural T cell responses in both patients and healthy individuals.CIITA is silenced by epigenetic mechanisms that prevent the recruitment of transactivating factors in rhabdomyosarcoma cells.The ganglioside antigen G(D2) is surface-expressed in Ewing sarcoma and allows for MHC-independent immune targeting.Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patientsEWS-FLI-1-targeted cytotoxic T-cell killing of multiple tumor types belonging to the Ewing sarcoma family of tumorsStrategies and developments of immunotherapies in osteosarcomaImmunotherapy in pediatric malignancies: current status and future perspectivesPilot Trial of FANG Immunotherapy in Ewing's Sarcoma.Ewing sarcoma dissemination and response to T-cell therapy in mice assessed by whole-body magnetic resonance imagingFibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer.Highlights of the First International "Immunotherapy in Pediatric Oncology: Progress and Challenges" Meeting.A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapyMolecular and cellular biology of rhabdomyosarcoma.Past, present and future of therapies in pediatric sarcomas.Approaching Ewing sarcoma.Cryoimmunology for malignant bone and soft-tissue tumors.Ewing sarcoma: biology-based therapeutic perspectives.Targeting the fetal acetylcholine receptor in rhabdomyosarcoma.A call to ARMS: targeting the PAX3-FOXO1 gene in alveolar rhabdomyosarcoma.Sarcoma immunotherapy: past approaches and future directions.Advances in therapy for pediatric sarcomas.Cellular immunotherapy strategies for Ewing sarcoma.Adoptive immunotherapy against sarcomas.Rhabdomyosarcoma in adults: new perspectives on therapy.Immunotherapy in Sarcoma: Future Horizons.
P2860
Q26747703-B0D93EF3-03E9-4C5D-8874-8A49D07C51DBQ26795369-75864993-B7B9-4062-AEE7-E5AADB44DA8DQ26829949-7CC040AF-CBF2-4DDD-9296-6A938E938461Q27009541-026861AE-403E-472D-868C-B19F3AD78105Q27014912-3EDCA220-F123-4999-842F-75F6411E5511Q28067036-224439AD-A3F0-4416-B2BE-79106EEF248CQ28088363-B71FA684-E52D-40B3-8A1B-6B02B3216D6BQ33604121-8C5A84B2-3C41-41CA-A1E1-3A43A0461EBFQ33680566-01FF41F1-D8A2-42DF-B56A-4B444BE93A00Q33750862-69E8BA29-E89C-4C26-9DCF-663CB7130882Q33752982-0D917464-4895-40D0-90A2-E261495D4C7DQ33758471-FB6CA7C5-D052-482A-89FC-A0F49F341361Q34196481-0FF826B3-ECE3-4BC9-9851-710883609D1DQ34262377-74443A94-FC6C-4E7D-AED6-3B77C8F3B598Q35000726-15E08411-C48B-4AA8-9DBF-C149DA8907AFQ35196739-1B8B44E7-965F-4A8B-AF3C-08F92DDC310EQ35729845-47CEB1B7-1D7D-4551-920B-3F1AF14283C3Q35832365-AC6AB766-B15B-4157-8BB3-B33D15CAFD14Q35965142-EACC26D5-FA75-4432-B5F2-DBDE56F0807DQ36295912-1E41F482-02CB-41FD-AF98-B6089DF0C01EQ36503128-CC586F52-90CA-4907-BD38-1A4298F60A9CQ36691818-D4E8C87A-690C-40A0-B748-D4A17CB5FC77Q36756669-FBE83DE1-1C97-41E4-B997-93A9E53B0E5DQ37081838-1CF2E970-0B6E-43D7-9C3A-CD12BD14AF6DQ37098831-4242A316-8D17-40CA-A3B6-5B7C8630B797Q37271276-663C8BAB-16EE-4ECA-939A-8BBB2674EBCEQ37366098-6A618C39-D4B0-4158-BA3E-82479AF2145BQ37630588-FE6B0879-DCE0-4AE6-98A0-F63CC0A563CCQ37725915-837EE53D-B1AE-4669-B28F-0D59D1CB52C6Q37771959-283FCB5A-5D94-4D5D-8BF3-AD923F8EF7AFQ37852619-191206DA-17AD-48AD-9A1E-DD52B32E73BEQ37981253-F9651748-97DB-4C60-A71A-1A633D086CCAQ38066542-A345C567-6ACA-4F2C-A815-DAF840F0FC0CQ38083828-4AD70556-690A-480D-B707-560173888D8FQ38207986-5367CB48-5983-4FAE-875B-92CE96BB49F6Q38217354-3F5520F4-8EAC-4356-A24E-43C2FFA25752Q38217594-EFA7D03D-9AE5-451F-8154-71CE8CB1F0E8Q38291193-1C535F75-9225-4185-9F3C-EBFA8809C70EQ38480485-85C3DF83-8413-4D4D-A371-30E04E19A801Q38596093-65C648CD-786D-4E88-8A5B-B328671B3AED
P2860
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
A pilot study of consolidative ...... high-risk pediatric sarcomas.
@ast
A pilot study of consolidative ...... high-risk pediatric sarcomas.
@en
type
label
A pilot study of consolidative ...... high-risk pediatric sarcomas.
@ast
A pilot study of consolidative ...... high-risk pediatric sarcomas.
@en
prefLabel
A pilot study of consolidative ...... high-risk pediatric sarcomas.
@ast
A pilot study of consolidative ...... high-risk pediatric sarcomas.
@en
P2093
P2860
P1476
A pilot study of consolidative ...... h high-risk pediatric sarcomas
@en
P2093
Crystal L Mackall
David Grindler
Donna Bernstein
Elizabeth J Read
Hanh M Khuu
Jay A Berzofsky
Lauren M Long
Lee J Helman
Margret Merino
Maria Tsokos
P2860
P304
P356
10.1158/1078-0432.CCR-07-4065
P407
P577
2008-08-01T00:00:00Z